Catenins, Wnt signaling and cancer

BioEssays

Volumn 22, Issue 11, 2000, Pages 961-965

  Barker, Nick ^a   Clevers, Hans ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYTOSKELETON PROTEIN; DESMOPLAKIN; ONCOPROTEIN; PLAKOGLOBIN; TRANSACTIVATOR PROTEIN; WNT PROTEIN; ZEBRAFISH PROTEIN;

ANIMAL; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; NEOPLASMS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0033777043     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-1878(200011)22:11<961::AID-BIES1>3.0.CO;2-T     Document Type: Review

References (39)

1. Mma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin
2. Identification of c-MYC as a target of the APC pathway
3. Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer
4. Beta-catenin: A key mediator of Wnt signaling
5. Cadherins and catenins: Role in signal transduction and tumor progression
6. Cytoskeleton-membrane interactions
7. Defining the interactions between intermediate filaments and desmosomes
8. The Yin-Yang of TCF/beta-catenin signaling
9. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
10. Control of beta-catenin signaling in tumor development
11. The control of beta-catenin and TCF during embryonic development and cancer
12. Beta-catenin is a target for the ubiquitin-proteasome pathway
13. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
14. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1
15. Cadherin cell adhesion receptors as a morpnogenetic regulator
16. Cadherins and catenins in development
17. Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways
18. Embryonic axis induction by the armadillo repeat domain of beta- catenin: Evidence for intracellular signaling
19. Anterior axis duplication in Xenopus induced by the over-expression of the cadherin-binding protein plakoglobin
20. Cytoplasmically anchored plakoglobin induces a WNT-like pnenotype in Xenopus
21. Localizing the adhesive and signaling functions of plakoglobin
22. Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion
23. Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin
24. Axin directly interacts with plakoglobin and regulates its stability
25. Analysis of the signaling activities of localization mutants of beta- catenin during axis specification in Xenopus
26. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin
27. Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin
28. Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro
29. Lack of beta-catenin affects mouse development at gastrulation
30. Beta-catenin signaling and cancer
31. β- and γ-catenin mutations, but not E-cadherin inactivation underlie T-Cell Factor/Lymphoid Enhancer Factor transcriptional deregulation in gastric and pancreatic cancer
32. Differential interaction of plakoglobin and beta-catenin with the ubiquitinproteasome system
33. Neoplastic transformation of by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
34. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates
35. The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression
36. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
37. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
38. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
39. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer